Nurses Can Help Mitigate Prostate Cancer Disparities

Video

Disparities exist across many cancer types, but they are particularly prevalent in patients with prostate cancer, explained Maggie A. Smith, DNP, MSN/Ed, RN, OCN, field medical director in GU Oncology at Pfizer, and Oncology Nursing News contributor.

African American men have some of the highest incidences and mortality rates from prostate cancer. To address this, oncology nurses can push for more inclusion in clinical trials, and educate their African American patients on the disease and prevention.

Recent Videos
image of a woman in front of a blue background with a navy top
woman with a white top sitting in front of a green wall
a man wearing a suit and tie in front of a green screen with the ONN logo
Related Content
yellow background with a white outline indicating kidneys

Belzutifan/Cabozantinib Shows Responses, Manageable Side Effects in First-Line ccRCC

Ashling Wahner
January 14th 2025
Article

Frontline treatment with belzutifan and cabozantinib resulted in durable responses and a manageable safety profile in patients with previously untreated advanced ccRCC.

The Vitals

Linda Bloom Shares Strategies To Improve Presurgical Communication With Patients Who Have Limited English Proficiency

Lindsay Fischer
August 14th 2023
Podcast

Linda Bloom, MPA, RN, OCN, highlights how tools such as audio interpretation technology and clear masks can help nurses and patients overcome communication barriers in oncology.

disparities in cancer care

Cancer Medication Adherence in the Latinx/Hispanic Community

Sara Grisales Jaramillo, MSW, LMSW
December 19th 2024
Article

Understanding psychosocial implications, barriers, risks, and impacts.

Oncology Nursing News

A Look Back at 2022 FDA Approvals in Oncology

Oncology Nursing News
January 2nd 2023
Podcast

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

prostate on a yellow background

FDA Accepts New Drug Application to Darolutamide Plus ADP for mHSPC

Chris Ryan
November 22nd 2024
Article

The FDA accepted a supplemental new drug application to darolutamide plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.

Person acute kidney injury Comprehensive image overview of kidneys showing sudden loss of function | Image Credit: © Premium Graphics - stock.adobe.com.

Opinion: Novel Risk Assessment Tool Helps Predict Cisplatin-Induced Acute Kidney Injury

Amanda Brink, DNP, APRN, FNP-BC, AOCNP
July 24th 2024
Article

Oncology nurses can utilize risk assessment to predict patients at increased risk for cisplatin-induced acute kidney injury.